Concepedia
Statistics
Publications
31
Citations
1.7K
H-Index
23
Active since
1992
Affiliations
Heidelberg University(Current)
University Hospital Heidelberg
German Cancer Research Center
Translational Research in Oncology
European Molecular Biology Laboratory
Susanne Dihlmann is an author at Heidelberg University specializing in medicine, inflammation, and life sciences.
Publications per year
1992–2023
The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling
Susanne Dihlmann, Anja Siermann, Magnus von Knebel Doeberitz · Oncogene · 2001 · 197 citations
Medicine, Pharmacology, Cell Signaling +13
Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients
Susanne Dihlmann, Fabian Echterdiek, Esther Herpel et al. · International Journal of Cancer · 2014 · 128 citations
Medicine, Cancer Biology, Oncology +16
Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin.
Susanne Dihlmann, Simone Klein, Magnus von Knebel Doeberitz Mv · PubMed · 2003 · 109 citations
Medicine, Oncology, Pharmacology +16
Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells
Georgios Patsos, Anja Germann, Johannes Gebert et al. · International Journal of Cancer · 2009 · 97 citations · Full text
Medicine, Cancer Biology, Oncology +14
Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.
Susanne Dihlmann, Johannes Gebert, Anja Siermann et al. · PubMed · 1999 · 94 citations
Medicine, Genetics, Oncology +17
1–5 of 31